The U.S. cell therapy market reached USD 3.9 Billion in 2024. IMARC Group projects it will grow to USD 10.0 Billion by 2033, at a CAGR of 11.1% from 2025 to 2033, driven by advancements in regenerative medicine, rising chronic disease cases, and increasing investment in personalized treatment solutions. https://www.imarcgroup.com/united-states-cell-therapy-market